XBIT
XBiotech Inc.
Key Financials
Net Income
$-45540000
↓ 18.2%
Operating Income
$-55685000
↓ 31.1%
Gross Profit
$0
↓ 100.0%
EPS (Diluted)
$-1.49
↓ 18.3%
Total Liabilities
$9.7M
↓ 42.2%
Total Assets
$150.1M
↓ 24.6%
Shareholders' Equity
$140.3M
↓ 23.0%
Cash & Equivalents
$125.6M
↓ 27.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/14/2026 | View on SEC |
| 10-K/A | 4/29/2026 | View on SEC |
| 10-K | 3/13/2026 | View on SEC |
| S-8 | 3/11/2026 | View on SEC |
| SCHEDULE 13G/A | 1/23/2026 | View on SEC |
| SCHEDULE 13G/A | 1/23/2026 | View on SEC |
| 8-K | 12/9/2025 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| 4 | 11/12/2025 | View on SEC |
| 4 | 11/12/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XBIT |
| Company Name | XBiotech Inc. |
| CIK | 1626878 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | 512-386-2900 |